ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04622	RIG-I-like receptor signaling pathway	4/29	62/7206	0.000100449725998
ko05212	Pancreatic cancer	4/29	83/7206	0.000312130478102
ko04621	NOD-like receptor signaling pathway	5/29	157/7206	0.000358305752297
ko04064	NF-kappa B signaling pathway	4/29	96/7206	0.000544228781853
ko04623	Cytosolic DNA-sensing pathway	3/29	41/7206	0.00056376328702
ko04620	Toll-like receptor signaling pathway	4/29	100/7206	0.000635302523829
ko05215	Prostate cancer	4/29	111/7206	0.000941102382307
ko05169	Epstein-Barr virus infection	5/29	206/7206	0.00123382030826
ko04066	HIF-1 signaling pathway	4/29	123/7206	0.00137981569254
ko05200	Pathways in cancer	7/29	492/7206	0.00276277434424
ko05160	Hepatitis C	4/29	153/7206	0.00306902680535
ko05140	Leishmaniasis	3/29	75/7206	0.00325791324003
ko04722	Neurotrophin signaling pathway	4/29	160/7206	0.00360602873507
ko00944	Flavone and flavonol biosynthesis	1/29	1/7206	0.00402442409104
ko05131	Shigellosis	3/29	82/7206	0.0041929426062
ko04657	IL-17 signaling pathway	3/29	87/7206	0.00495127562651
ko05133	Pertussis	3/29	87/7206	0.00495127562651
ko05206	MicroRNAs in cancer	4/29	177/7206	0.00517048284053
ko04920	Adipocytokine signaling pathway	3/29	89/7206	0.0052763461202
ko05222	Small cell lung cancer	3/29	89/7206	0.0052763461202
ko05168	Herpes simplex infection	4/29	182/7206	0.00570566261841
ko05152	Tuberculosis	4/29	187/7206	0.00627694142561
ko01523	Antifolate resistance	2/29	30/7206	0.00634427954649
ko05132	Salmonella infection	3/29	98/7206	0.00689746278905
ko05162	Measles	3/29	120/7206	0.0120046133893
ko04668	TNF signaling pathway	3/29	120/7206	0.0120046133893
ko05145	Toxoplasmosis	3/29	126/7206	0.0136913086945
ko05142	Chagas disease (American trypanosomiasis)	3/29	130/7206	0.0148875919613
ko04380	Osteoclast differentiation	3/29	134/7206	0.0161418118303
ko05321	Inflammatory bowel disease (IBD)	2/29	56/7206	0.0210577196139
ko05203	Viral carcinogenesis	4/29	277/7206	0.0237976764535
ko04024	cAMP signaling pathway	4/29	279/7206	0.0243610596298
ko05221	Acute myeloid leukemia	2/29	63/7206	0.026247123802
ko04071	Sphingolipid signaling pathway	3/29	162/7206	0.0265654563172
ko05166	HTLV-I infection	4/29	292/7206	0.0282232792288
ko05164	Influenza A	3/29	167/7206	0.0287315660128
ko05161	Hepatitis B	3/29	173/7206	0.0314527545722
ko05030	Cocaine addiction	2/29	73/7206	0.0344584396741
ko04210	Apoptosis	3/29	180/7206	0.0347949221612
ko05134	Legionellosis	2/29	74/7206	0.0353285063188
ko01524	Platinum drug resistance	2/29	76/7206	0.0370943009275
ko04010	MAPK signaling pathway	4/29	321/7206	0.038114182779
ko05167	Kaposi's sarcoma-associated herpesvirus infection	3/29	191/7206	0.0404087079139
ko05220	Chronic myeloid leukemia	2/29	85/7206	0.0454485843327
ko04062	Chemokine signaling pathway	3/29	201/7206	0.0458915748129
ko04917	Prolactin signaling pathway	2/29	87/7206	0.0473922179214
ko04662	B cell receptor signaling pathway	2/29	88/7206	0.0483754732218